Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 20, 2017
Pharmacy Choice - News - Drug Delivery Systems - November 20, 2017

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

11/13/17 - "Orally Disintegrating Solid Pharmaceutical Dosage Unit Containing a Partus Control Substance" in Patent Application Approval Process (USPTO...
"Orally Disintegrating Solid Pharmaceutical Dosage Unit Containing a Partus Control Substance" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors PLATTEEUW, Johannes Jan; COELINGH BENNINK, Herman Jan Tijmen, filed on September 29, 2015, was made available onli
11/13/17 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 45596) - Meeting
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting of the Antimicrobial Drugs Advisory Committee to discuss new drug application 209367, ciprofloxacin inhalation powder, sponsored by Bayer HealthCare Pharmaceuticals, Inc., for the proposed indication of reduction of exacerbations in non-cystic fibrosis...
11/13/17 - Medicure Acquires Exclusive License to Sell and Market PREXXARTAN in the U.S. from Carmel Biosciences
By a News Reporter-Staff News Editor at Pharma Business Week Medicure Inc., a specialty pharmaceutical company, announced that, through its subsidiary, Medicure International Inc., it has acquired an exclusive license to sell and market PREXXARTAN oral solution in the United States and its territories from Carmel Biosciences, Inc. for a seven
11/13/17 - Neos Therapeutics to Present at the Stifel 2017 Healthcare Conference
DALLAS- Neos Therapeutics, Inc., a pharmaceutical company focused on developing, manufacturing, and commercializing innovative extended-release products using its proprietary modified-release drug delivery and orally disintegrating tablet technology platforms, today announced that Vipin K. Garg, Ph.D., President and CEO of Neos Therapeutics, will..
11/13/17 - Novaliq's NovaTears Treatment for Evaporative Dry Eye Disease Launches in New Zealand and Receives Registrational Approval in Australia
By a News Reporter-Staff News Editor at Clinical Trials Week Novaliq GmbH, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, announced the launch of NovaTears in New Zealand and registrational approval in Australia. In March 2017, Nova
11/13/17 - Novartis submits application to FDA for Kymriah tisagenlecleucel in adult patients with r/r DLBCL, seeking second indication for first-ever FDA...
Novartis submits application to FDA for Kymriah tisagenlecleucel in adult patients with r/r DLBCL, seeking second indication for first-ever FDA approved CAR-T therapy. In August 2017, Kymriah became the first available chimeric antigen receptor T cell therapy when it received FDA approval five weeks prior to its PDUFA date and was launched for pati
11/13/17 - Smart artificial beta cells could lead to new diabetes treatment
By a News Reporter-Staff News Editor at Diabetes Week CHAPEL HILL, NC- Treating type 1 diabetes and some cases of type 2 diabetes has long required painful and frequent insulin injections or a mechanical insulin pump for insulin infusion. "Our plan now is to further optimize and test these synthetic cells in larger animals, develop a skin patch
11/13/17 - Teva Announces Completion of PARAGARD Divestiture to CooperSurgical
By a News Reporter-Staff News Editor at Pharma Business Week Teva Pharmaceutical Industries Ltd., announced it has completed the divestiture of PARAGARD to CooperSurgical in a $1.1 billion cash transaction. "We now have an infusion of $1.1 billion to progress the repayment of term loan debt and are on track to deliver on our promise to genera
11/13/17 - Teva Wins Generic Uceris Patent Trial
By a News Reporter-Staff News Editor at Pharma Business Week Teva Pharmaceutical Industries Ltd., announced that the United States District Court for the District of Delaware has ruled in the Company's favor in patent litigation involving Teva's abbreviated new drug application directed to a generic version of Valeant's Uceris tablets.
11/12/17 - New Findings in Transdermal Delivery Described from Toho University (Assessment of a novel transdermal selective beta 1-blocker, the bisoprolol...
New Findings in Transdermal Delivery Described from Toho University. By a News Reporter-Staff News Editor at Heart Disease Weekly A new study on Drugs and Therapies- Transdermal Delivery is now available. The news correspondents obtained a quote from the research from Toho University, "Recently, the bisoprolol patch, a novel transdermal beta 1- b
11/11/17 - Mesoblast Phase 2 Trial Results Show Early and Durable Effects of Single Mesenchymal Precursor Cell Infusion in Biologic Refractory Rheumatoid Arthritis Patients [Tehran Times (Iran)]
-Mesoblast Limited today announced that results from the randomized, placebo-controlled Phase 2 trial of its proprietary allogeneic mesenchymal precursor cells over 52 weeks in patients with biologic refractory rheumatoid arthritis were presented at the 2017 American College of Rheumatology Annual Meeting held this week in San Diego, CA..
11/10/17 - Amgen And Allergan Receive Positive CHMP Opinion For ABP 215 (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer
Amgen and Allergan plc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion for the Marketing Authorization of ABP 215, a biosimilar to Avastin . "ABP 215 has the potential to provide healthcare professionals and appropriate patients across Europe access to hig
11/10/17 - BENRALIZUMAB POSITIVE CHMP IN EOSINOPHILIC ASTHMA
10 November 2017 11:35 GMT. AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion, recommending the marketing authorisation of benralizumab as an add-on maintenance treatment in adult patien
11/10/17 - Benralizumab receives positive EU CHMP opinion for severe, uncontrolled eosinophilic asthma
Benralizumab uniquely targets and rapidly depletes eosinophils and is the first respiratory biologic with an 8- week maintenance dosing schedule. AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positiv
11/10/17 - Beximco Pharma commenced its second product export to the US
Beximco Pharmaceuticals Limited, the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announces it has commenced the export of Sotalol Hydrochloride, a generic version of the cardiovascular drug Betapace, to the US. With the export of our first product to the US in August 2016, we began a new
11/10/17 - Bristol-Myers Says FDA Expands Approval Of Sprycel
NEW YORK CITY- Bristol-Myers Squibb Co. announced the U.S. Food and Drug Administration has expanded the indication for Sprycel or dasatinib tablets to include the treatment of children with Philadelphia chromosome-positive or Ph+ chronic myeloid leukemia or CML in chronic phase or CP. As part of its commitment to children and adolescents with canc
11/10/17 - Data on Drug Delivery Systems Reported by Researchers at University of Minnesota (A Structural and Fluid-Flow Model for Mechanically Driven...
Data on Drug Delivery Systems Reported by Researchers at University of Minnesota. According to news reporting out of Minneapolis, Minnesota, by NewsRx editors, research stated, "The primary focus of this research is the design of wall-driven peristaltic pumps based on first principles with minimal simplifying assumptions and implementation by numer
11/10/17 - E Ink and LTS Partner to Develop Smart Patch to Improve Medical Management
By a News Reporter-Staff News Editor at Drug Week E Ink Holdings, "E Ink", the leading innovator of electronic ink technology and LTS Lohmann-Therapie Systeme AG, "LTS" leading in the development and manufacturing of transdermal therapeutic systems, announced their partnership to develop a "Smart Patch" prototype. The Smart Patch prototype is a t
11/10/17 - Fate Therapeutics Announces Initial Clinical Data from Ongoing First-in-Human VOYAGE Study of FATE-NK100 for Relapsed / Refractory Acute Myelogenous Leukemia at SITC 2017 Annual Meeting
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced today initial clinical data from the ongoing VOYAGE Phase 1 study of FATE- NK100 as a monotherapy for the treatment of refractory or relapsed acute myelogenous leukemia.
11/10/17 - Findings from Kyushu University Provides New Data on Drug Delivery Systems (Nanoparticle-mediated drug delivery system for atherosclerotic...
Findings from Kyushu University Provides New Data on Drug Delivery Systems. According to news reporting out of Fukuoka, Japan, by NewsRx editors, research stated, "Administration of drugs and other therapeutic agents has been the central strategy of contemporary medicine for cardiovascular disease. Our news journalists obtained a quote from the res
11/10/17 - InfuSystem Holdings, Inc. Reports Third Quarter 2017 Financial Results
InfuSystem Holdings, Inc., a leading national provider of infusion pumps and related services for the healthcare industry in the United States, today reported financial results for the quarter ended September 30, 2017. Net revenues totaled $17.6 million, an increase of 2.1%, versus the third quarter of 2016 of $17.2 million Rental revenues increa
11/10/17 - Investigators from Department of Chemistry Have Reported New Data on Drug Delivery Systems [Controlled release of Doxycycline from gum...
Our news editors obtained a quote from the research from the Department of Chemistry, "The dynamic release of Doxycycline was investigated in the physiological fluids at 37 degrees C. Various kinetic models such as Power function model, Schott model and Higuchi model were applied to interpret the release data. For more information on this research
11/10/17 - New Antiinfectives Findings from Cordoba National University Reported (Bioadhesive and biocompatible films as wound dressing materials based on a...
According to news reporting originating in Cordoba, Argentina, by NewsRx journalists, research stated, "The bioadhesive polymeric films as topical drug delivery systems are interesting alternatives to improve the pharmacotherapy and patient compliances. The news reporters obtained a quote from the research from Cordoba National University, "Relevan
11/10/17 - New Drug Delivery Systems Findings from National Institute of Technology Described (Solid silicon microneedles for drug delivery applications)
By a News Reporter-Staff News Editor at Drug Week Research findings on Drugs and Therapies- Drug Delivery Systems are discussed in a new report. According to news reporting originating from Tiruchirappalli, India, by NewsRx correspondents, research stated, "In this work, solid silicon microneedles with a higher aspect ratio and sharper tips are f
11/10/17 - Novaer Holdings Assigned Patent for Drug Delivery Devices
Novaer Holdings, Bedminster, New Jersey, has been assigned a patent developed by three co-inventors for "drug delivery devices for delivery of ocular therapeutic agents." The co-inventors are Casey Kopczynski, Chapel Hill, North Carolina, Cheng-Wen Lin, Durham, North Carolina, and Chris Sutay, Raleigh, North Carolina. Written by Amal Ahmed; edited
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415